Yong Serk Park

RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo

Si Eun Baek, Kwang Hyun Lee, Yong Serk Park et al. · Journal of Controlled Release · 2014 · 143 citations

Pharmacy, Oncology, Pharmaceutics +16

Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer

Min Woo Kim, Hwa Yeon Jeong, Seong Jae Kang et al. · Theranostics · 2019 · 127 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles

Min Woo Kim, Hwa Yeon Jeong, Seong Jae Kang et al. · Scientific Reports · 2017 · 75 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Immuno-PET Imaging and Radioimmunotherapy of ⁶⁴Cu-/¹⁷⁷Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model

In Ho Song, Tae Sup Lee, Yong Serk Park et al. · Journal of Nuclear Medicine · 2016 · 63 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N-lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate)

Hong Sung Kim, In Ho Song, Jong Chul Kim et al. · Journal of Controlled Release · 2006 · 62 citations

Pharmacy, Biochemistry, Cell Biology +6